A novel [Mn<sub>2</sub>(μ-(C<sub>6</sub>H<sub>5</sub>)<sub>2</sub>CHCOO)<sub>2</sub>(bipy)<sub>4</sub>](bipy)(ClO<sub>4</sub>)<sub>2</sub> complex loaded solid lipid nanoparticles: synthesis, characterization and in vitro cytotoxicity on MCF-7 breast cancer cells.

Eskiler G. G., Cecener G., Dikmen G., Kani I., Egeli Ü., Tunca B.

Journal of microencapsulation, cilt.33, sa.6, ss.575-584, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1080/02652048.2016.1228704
  • Dergi Adı: Journal of microencapsulation
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.575-584
  • Anahtar Kelimeler: Metal-based ligands, Mn(II) complex, 2,2 '-bipyridine, drug delivery systems, solid lipid nanoparticles (SLNs), cancer, DRUG-DELIVERY-SYSTEMS, ANTICANCER DRUGS, MANGANESE(II) COMPLEX, CAFFEIC ACID, FUTURE, FORMULATION, COPPER(II), RESISTANCE, LIGAND
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

© 2016 Informa UK Limited, trading as Taylor & Francis Group.Manganese (Mn)-based complexes have been drawing attention due to the fact that they are more effective than other metal complexes. However, the use of Mn(II)-based complexes in medicine remains limited because of certain side effects. The aim of this study was to investigate the cytotoxic and apoptotic effects of a novel Mn(II) complex [Mn2(μ-(C6H5)2CHCOO)2(bipy)4](bipy)(ClO4)2 and Mn(II) complex loaded solid lipid nanoparticles (SLNs) on MCF-7 and HUVEC control cells. The average diameter of Mn(II) complex was about 1120 ± 2.43 nm, while the average particle size of Mn(II) complex-SLNs was ∼340 ± 2.27 nm. The cytotoxic effects of Mn(II) complex and Mn(II)-SLNs were 86.8 and 66.4%, respectively (p <.05). Additionally, both Mn(II) complex (39.25%) and Mn(II)-SLNs (38.05%) induced apoptosis and increased the arrest of G0/G1 phase. However, Mn(II) complex exerted toxic effects on the HUVEC control cell (63.4%), whereas no toxic effects was observed when treated with Mn(II)-SLNs at 150 μM. As a consequence, SLNs might be potentially used for metal-based complexes in the treatment of cancer due to reducing size and toxic effects of metal-based complexes.